Marketing-authorisation holder
Janssen Prods
10 medicines in 1 country, as authorisation holder.
Loadingโฆ
Marketing-authorisation holder
10 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| EDURANT25mg base ยท Tablet | Rilpivirine | United States | Marketed | 2011 |
| EDURANT PED2.5mg base ยท Tablet, for suspension | Rilpivirine | United States | Marketed | 2024 |
| OLYSIO150mg base ยท Capsule | Simeprevir | United States | Not marketed | 2013 |
| PREZCOBIX600mg/90mg | 675mg/150mg ยท Tablet, for suspension | Darunavir, Cobicistat | United States | Marketed | 2026 |
| PREZCOBIX150mg; 675mg base | 150mg; 800mg base ยท Tablet | Cobicistat, Darunavir | United States | Marketed | 2015 |
| PREZCOBIX PED90mg; 600mg base ยท Tablet, for suspension | Cobicistat, Darunavir | United States | Marketed | 2026 |
| PREZISTA100mg/ml ยท Suspension | Darunavir | United States | Marketed | 2011 |
| PREZISTA150MG | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 600MG | 75MG | 800MG ยท Tablet | Darunavir | United States | Marketed | 2006 |
| SYMTUZA150mg; 800mg; 200mg; 10mg base ยท Tablet | Cobicistat, Darunavir, Emtricitabine, Tenofovir alafenamide | United States | Marketed | 2018 |
| YONDELIS1mg/vial ยท Powder | Trabectedin | United States | Marketed | 2015 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 10 | 10 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Keep Janssen Prodsโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callOther companies in the same group.